1 completed, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Chronic Kidney Insufficiency: new trials by email Literature Review of Chronic Kidney Insufficiency trials Research Report on Chronic Kidney Insufficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRP TOUR006 - 50 MG, TOUR006 - 25 MG, TOUR006 - 15 MG - Chronic Kidney Diseases, Chronic Kidney Insufficiency | Phase 2 | Completed | Tourmaline Bio, Inc., a Novartis Company | 143 | 2024-05-15 | 2026-08-11 |
| EPLErenone in CsA-Treated Recipients (EpleCsAT): Safety Eplerenone - Chronic Kidney Insufficiency, Kidney Transplantation | Phase 2 | Unknown | CHU de Reims | 31 | 2013-02-01 | 2013-04-18 |
Renal Insufficiency, Chronic (2)
Chronic Disease (2) · Disease Attributes (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Renal Insufficiency (2) · Urogenital Diseases (2) · Urologic Diseases (2)
Eplerenone (1)
CHU de Reims (1) · Tourmaline Bio, Inc., a Novartis Company (1)
France (1) · United States (1)